Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer

.blurhash-client-img { display: none !important; }

Open Access

|Aug 2020

Authors

Urology Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Department of Physiology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Department of Pathophysiology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Nephrology Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Urology Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Urology Clinic, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina

DOI: https://doi.org/10.2478/rjim-2020-0008 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749

Language: English

Page range: 146 - 152

Submitted on: Feb 14, 2020

Published on: Aug 10, 2020

Published by: N.G. Lupu Internal Medicine Foundation

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2020 Zahid Lepara, Orhan Lepara, Almir Fajkić, Damir Rebić, Jasmin Alić, Hajrudin Spahović, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.